Figure 1: Disease-free survival of patients with locally advanced rectal cancer receiving capecitabine/irinotecan +/− cetuximab based chemoradiotherapy as preoperative treatment (). Shown are survival curves of patients treated with CapIri (solid curve; ) versus patients treated with CapIri + cetuximab (dotted curve; ), .